Yeast-based vaccines as immunotherapy

Details Yeast-based vaccines as immunotherapy Yeast-based vaccines as immunotherapy

2003-12-16

2008-12-16

Fetterolf, Brandon J (Department: 1642)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C424S093200, C424S093500, C424S093510

Reexamination Certificate

active

07465454

ABSTRACT:
Compositions and methods for treating and/or preventing a variety of diseases and conditions that are amenable to immunotherapy and, in one particular embodiment, compositions and methods for treating and/or preventing cancer in an animal are described. Specifically improvements related to the use of a yeast-based vaccine comprising a yeast vehicle and an antigen that is selected to elicit an antigen-specific cellular and humoral immune response in an animal, for use in prophylactic and/or therapeutic vaccination and the prevention and/or treatment of a variety of diseases and conditions are disclosed.

REFERENCES:
patent: 4775622 (1988-10-01), Hitzeman et al.
patent: 5413914 (1995-05-01), Franzusoff
patent: 5527676 (1996-06-01), Vogelstein et al.
patent: 5830463 (1998-11-01), Duke et al.
patent: 5858378 (1999-01-01), Bostwick
patent: 5919651 (1999-07-01), Hitzeman et al.
patent: 5961978 (1999-10-01), Gaudernack et al.
patent: 6090546 (2000-07-01), Breivik et al.
patent: 6187307 (2001-02-01), Cohen
patent: 6558951 (2003-05-01), Tomai et al.
patent: 6759046 (2004-07-01), Gaudernack et al.
patent: 6861057 (2005-03-01), Gaudernack et al.
patent: 7083787 (2006-08-01), Duke et al.
patent: 2002/0155108 (2002-10-01), Barbera-Guillem
patent: 2003/0035810 (2003-02-01), Caplan
patent: 2004/0072759 (2004-04-01), Gaudernack et al.
patent: 2005/0074849 (2005-04-01), Gaudernack et al.
patent: 2486400 (1982-01-01), None
patent: WO 0129233 (2001-04-01), None
patent: WO 02/39951 (2002-05-01), None
Ben-Efraim, S. (Tumor Biology 1999; 20: 1-24).
North (Adv. Immunol 1984; 35: 89-155).
Marincola et al. (Trends in Immunology 2003; 24: 334-341).
Frazer, I. (Expert. Opin. Pharmacother. 2004; 5: 2427-2434).
Granziero et al. (Eur. J. Immunol. 1999, 29:1127-1138).
Byers, T. (CA Journal, vol. 49, No. 6, Nov./Dec. 1999).
Rosenberg et al. (The New England Journal of Cancer 2004; 350: 1461-1463).
Bodey et al. (Anticancer Research 2000; 20: 2665-2676).
Schlegel et al. (Journal of Neuro-Oncology 1992; 14: 93-100.
Adams et al. International Reviews of Immunology, vol. 11 No. 2, pp. 133-141 (1994).
Allsopp et al., European Journal of Immunology, vol. 26 No. 8, pp. 1951-1959 (1996).
Bachmann et al., 1994,Curr. Op. Immunol., 6:320-326.
Baker et al., 1988,Cell, 54:335-344.
Bizzini et al., 1990,FEMS Microbiol. Immunol., 64:155-168.
Bourdette et al., 1994,J. Immunol., 152:2510-2519.
Brake et al., 1984,Proc. Natl. Acad. Sci. USA, 81:4642-4646.
Brown, D., 1995,The Washington Post,“Gene Therapy ‘Oversold’ by Researchers, Journalists”.
Chou et al., 1994,J. Immunol., 152:2520-2529.
Coghlan, 1995,New Scientists, 145:14-15.
Cohen, 1994,Science, 264:1660.
Cohen, 1994,Science, 264:1839.
Davies et al., 1992,Nucleic Acids Res., 20(11):2693-2698.
Demmer et al., 1993,J. Immunol., 150(12):5371-5378.
Engelhardt et al., 1994,Hum. Gene Ther, 5:1217-1229.
Fattal-German et al., 1992,Develop. Biol. Standard., 77:115-120.
Franzusoff et al., 1995,J. Biol. Chem., 270(7):3154-3159.
Fujita et al., 1987,Bulletin of the World Health Organization, 65(3):303-308.
Garber et al., AIDS Reviews, vol. 5 No. 3, pp. 131-139 (2003).
Gnirke et al., 1991,EMBO J., 10(7):1629-1634.
Gobin et al., 1995,Gene, 163:27-33.
Hatsuyama et al., 1994,Plant Cell Physiol., 35(1):93-98.
Kaur et al., Topics in HIV Medicine, vol. 11 No. 3, pp. 76-85 (2003).
Ketner et al., 1994,Proc. Natl. Acad. Sci. USA, 91:6186-6190.
Layton et al. Immunology, vol. 87 No. 2, pp. 171-178 (1996).
Markie et al., 1993,Somat. Cell Mol. Genet., 19(2):161-169.
Marshall, 1995,Science269:1050-1055.
Moore et al., 1996,FASEB J., 10(6) Abstract 2725.
Moulard et al., 1994,Eur. J. Biochem. 225:565-572.
Mullen et al., 1994,Plant Physiol., 105:113 (Abstr. 606).
Mulligan, 1993,Science, 260:926-931.
Pachnis et al., 1990,Proc. Natl. Acad. Sci. USA, 87:5109-5113.
Paglia et al., Journal of Experimental Medicine, vol. 183 No. 1, pp. 317-322 (1996).
Peterson et al., 1993,Proc. Natl. Acad. Sci. USA, 90:11207-11211.
Rabinovich et al., 1994,Science, 265:1401-1404.
Sanchez-Pescador et al., 1985,Science, 227:484-492.
Schreuder et al., 1996Vaccine, 14(5):383-388.
Sousa et al., Journal of Experimental Medicine, vol. 178 No. 2, pp. 509-519 (Aug. 1993).
Stern et al., 1992,Cell, 68:465-477.
Suda et al., 1993,Cell, 75:1169-1178.
Valenzuela et al., 1985Bio/Technology3:323-326.
Brossier et al., Infection and Immunity, vol. 67, No. 2, Feb. 1999, pp. 964-967.
U.S. Appl. No. 11/768,144, filed Jun. 25, 2007, Franzusoff et al.
Stubbs et al. “Whole recombinant yeast vaccine activates dendric cells and elicits protective cell-mediated immunity”, Nature Medicine May 2001, vol. 7, pp. 1-5.
International Search Report for International (PCT) Patent Application No. PCT/US03/40281, mailed Sep. 22, 2006.
International Preliminary Examination Report for International (PCT) Patent Application No. PCT/US03/40281, mailed Sep. 22, 2006.
Supplementary European Search Report for European Application No. EP 03 81 4130, European Regional Phase of PCT Application No. PCT/US03/40281; Search Report issued Apr. 24, 2008.
English translation of Comments of the Examiner, First Office Action for Chinese Application No. 200380109787.5, Chinese National Phase of PCT Application No. PCT/US04/040281; Jun. 2008.

Affiliated with

Also associated with

Rating

Yeast-based vaccines as immunotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Yeast-based vaccines as immunotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Yeast-based vaccines as immunotherapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4021160